RxDoctor Payments Data

Stephanie Dadario, PA

Physician Assistant · Cranston, RINPI 1740210509

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.0% of the total across 235 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Johnson & Johnson at 35.2% of the total. Reporting peaked in 2023 at $2,241 and has fallen 91.8% since, to $184 in 2025. Among physician assistant clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,833in general payments, 2019–2025

Across 235 payments — averaging $20.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • AbbVie$798
  • E.r. Squibb & Sons, L.L.C.$534
  • Sanofi$466
  • LEO Pharma Inc.$316
  • Incyte Corporation$262
  • plus $756 from 11 others

What the payments were for

  • Food & beverage$4,59195%
  • Education$2425%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,833 in reported general payments places this provider in the 90th percentile of 481 physician assistant providers in Rhode Island.

See all physician assistant providers in Rhode Island

Medicare billing

Part B allowed, 2024
$93,816
Medicare patients
492
Services billed
1,931

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil79$4,881
Clobetasol Propionate108$4,367
Betamethasone Dipropionate97$4,354
Ketoconazole241$3,955
Triamcinolone Acetonide167$2,705
Tacrolimus13$2,694
Doxycycline Hyclate90$1,937
Calcipotriene20$1,887
Nystatin80$1,495
Mometasone Furoate86$1,421
Clindamycin Phosphate32$1,382
Metronidazole31$1,371
Ciclopirox23$1,047
Sulfacetamide Sodium11$939
Ammonium Lactate31$686

Paid to pharmacies, not to this prescriber.

Other physician assistant in Cranston

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →